Skip to search formSkip to main contentSkip to account menu

APO 866

Known as: APO-866, APO866, NMPRTase Inhibitor APO866 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Introduction: Adult T-cell leukemia/lymphoma (ATL) is an aggressive peripheral T-cell neoplasm that develops after long-term… 
2015
2015
e20044 Background: Cutaneous T-cell lymphoma (CTCL) is characterized by the accumulation of clonal T-cells in the skin. Given the… 
2014
2014
Abstract APO866 is an inhibitor of nicotinamide adenine dinucleotide (NAD) biosynthesis that exhibits potent anti-lymphoma… 
2013
2013
Introduction APO866 is a new anti-tumor compound inhibiting nicotinamide phosphoribosyltransferase (NAMPT). APO866 has an anti… 
2013
2013
Background It has been recently demonstrated that a pro-inflammatory adipokine called visfatin can be produced by chondrocytes in… 
2011
2011
Pre-B cell colony-enhancing factor ([PBEF] also known as Nampt/visfatin) is a pleiotropic 52-kDa cytokine-like molecule whose… 
2009
2009
To the editor: We read with interest the elegant studies of Koyama and colleagues[1][1] in which they demonstrate the ability of…